FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frances O'Malley

Research Profile

Disorders

Procedures

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Predictive Value of Tests

Co-author Network

Publications

TOP 3
Catherine L Forse; Anna Marie Mulligan; Frances P O'Malley; Dushanthi Pinnaduwage; Yildiz E Yilmaz; Shelley B Bull; Irene L Andrulis
Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer.
Anna Marie Mulligan; Linh T Nguyen; Pamela S Ohashi; Frances P O'Malley; Dushanthi Pinnaduwage; Irene Raitman; Linda Feeley; Irene L Andrulis
Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry.
Kathleen I Pritchard; Wendy Shelley; Peter Lovrics; David McCready; Frances P O'Malley; Francisco Perera; Audley Bodurtha; Nancy Down; Leela Elavathil; Ralph George; Karen Yvonne Gulenchyn; Nicole Hodgson; Claire M B Holloway; Jim A Julian; Mark N Levine
Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frances O'Malley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Catherine L Forse; Anna Marie Mulligan; Frances P O'Malley; Dushanthi Pinnaduwage; Yildiz E Yilmaz; Shelley B Bull; Irene L Andrulis
Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer.
Breast cancer research and treatment 2013;137(3):709-19.
2013: Anna Marie Mulligan; Linh T Nguyen; Pamela S Ohashi; Frances P O'Malley; Dushanthi Pinnaduwage; Irene Raitman; Linda Feeley; Irene L Andrulis
Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(2):336-46.
2012: Kathleen I Pritchard; Wendy Shelley; Peter Lovrics; David McCready; Frances P O'Malley; Francisco Perera; Audley Bodurtha; Nancy Down; Leela Elavathil; Ralph George; Karen Yvonne Gulenchyn; Nicole Hodgson; Claire M B Holloway; Jim A Julian; Mark N Levine
Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(12):1274-9.
2011: Frances P O'Malley; Lois E Shepherd; Dongsheng Tu; Irene L Andrulis; Vivien H C Bramwell; S Chia; D Huntsman; Mark N Levine; Kathleen I Pritchard
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.
Breast cancer research and treatment 2011;128(2):401-9.
2011: Anita L Bane; Anna Marie Mulligan; Dushanthi Pinnaduwage; Frances P O'Malley; Irene L Andrulis
EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
Breast cancer research and treatment 2011;127(3):831-9.
2011: Anna Marie Mulligan; Dushanthi Pinnaduwage; Anita L Bane; Shelley B Bull; Frances P O'Malley; Irene L Andrulis
CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry.
Cancer 2011;117(7):1350-9.
2010: Frances P O'Malley
Lobular neoplasia: morphology, biological potential and management in core biopsies.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23 Suppl 2():S14-25.
2009: Andrea Grin; Frances P O'Malley; Anna Marie Mulligan
Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
The American journal of surgical pathology 2009;33(11):1615-23.
2009: Anita L Bane; Dushanthi Pinnaduwage; Sarah Colby; Michael Reedijk; Sean E Egan; Shelley B Bull; Frances P O'Malley; Irene L Andrulis
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.
Breast cancer research and treatment 2009;117(1):183-91.
2009: Alicia M Viloria-Petit; Laurent David; Jun Yong Jia; Tuba Erdemir; Anita L Bane; Dushanthi Pinnaduwage; Luba Roncari; Masahiro Narimatsu; Rohit Bose; Jason Moffat; John Wong; Robert S Kerbel; Frances P O'Malley; Irene L Andrulis; Jeffrey L Wrana
A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(33):14028-33.
2009: Frances P O'Malley; S Chia; Dongsheng Tu; Lois E Shepherd; Mark N Levine; Vivien H C Bramwell; Irene L Andrulis; Kathleen I Pritchard
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.
Journal of the National Cancer Institute 2009;101(9):644-50.
2009: Andrea Grin; Garnet Horne; Marguerite Ennis; Frances P O'Malley
Measuring extent of ductal carcinoma in situ in breast excision specimens: a comparison of 4 methods.
Archives of pathology & laboratory medicine 2009;133(1):31-7.
2008: Bindi Dhesy-Thind; Kathleen I Pritchard; Hans Messersmith; Frances P O'Malley; Leela Elavathil; Maureen Trudeau
HER2/neu in systemic therapy for women with breast cancer: a systematic review.
Breast cancer research and treatment 2008;109(2):209-29.
2008: Kathleen I Pritchard; Hans Messersmith; Leela Elavathil; Maureen Trudeau; Frances P O'Malley; Bindi Dhesy-Thind
HER-2 and topoisomerase II as predictors of response to chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):736-44.
2008: Frances P O'Malley; Tom Thomson; Jim Julian; Cherry Have; Roxanne Cosby; Roxanne Crosby; Karen Gelmon; Irene Andrulis; Timothy Whelan
HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab.
Archives of pathology & laboratory medicine 2008;132(1):61-5.
2008: Frances P O'Malley; Anita L Bane
An update on apocrine lesions of the breast.
Histopathology 2008;52(1):3-10.
2007: A M Scaranelo; Karina Bukhanov; P Crystal; Anna Marie Mulligan; Frances P O'Malley
Granular cell tumour of the breast: MRI findings and review of the literature.
The British journal of radiology 2007;80(960):970-4.
2007: Anna Marie Mulligan; Frances P O'Malley; Marguerite Ennis; I George Fantus; Pamela J Goodwin
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.
Breast cancer research and treatment 2007;106(1):39-47.
2007: Ruoyu Ni; Anna Marie Mulligan; Cherry Have; Frances P O'Malley
PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(3):316-24.
2007: Jane C Figueiredo; Marguerite Ennis; Julia A Knight; John R McLaughlin; Nicky Hood; Frances P O'Malley; Irene L Andrulis; Pamela J Goodwin
Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Breast cancer research and treatment 2007;105(1):69-80.
2007: Brendan C Dickson; Anna Marie Mulligan; Hui Zhang; Gina Lockwood; Frances P O'Malley; Sean E Egan; Michael Reedijk
High-level JAG1 mRNA and protein predict poor outcome in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(6):685-93.
2007: Anna Marie Mulligan; Frances P O'Malley
Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases.
International journal of surgical pathology 2007;15(2):143-7.
2007: Anna Marie Mulligan; Frances P O'Malley
Papillary lesions of the breast: a review.
Advances in anatomic pathology 2007;14(2):108-19.
2007: Anita L Bane; Jeanne C Beck; Ira J Bleiweiss; Saundra S Buys; Edison Catalano; Mary B Daly; Graham Giles; Andrew K Godwin; Hanina Hibshoosh; John L Hopper; Esther M John; Lester J Layfield; Teri A Longacre; alexander miron; Rubie Senie; Melissa C Southey; Dee W West; Alice S Whittemore; Hong Wu; Irene L Andrulis; Frances P O'Malley
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
The American journal of surgical pathology 2007;31(1):121-8.
2006: Teresa L Mastracci; Ashleen Shadeo; Sarah M Colby; Alan B Tuck; Frances P O'Malley; Shelley B Bull; Wan L Lam; Irene L Andrulis
Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast.
Genes, chromosomes & cancer 2006;45(11):1007-17.
2006: Kathleen I Pritchard; Lois E Shepherd; Frances P O'Malley; Irene L Andrulis; Dongsheng Tu; Vivien H C Bramwell; Mark N Levine
HER2 and responsiveness of breast cancer to adjuvant chemotherapy.
The New England journal of medicine 2006;354(20):2103-11.
2006: Teri A Longacre; Marguerite Ennis; Louise A Quenneville; Anita L Bane; Ira J Bleiweiss; Beverley A Carter; Edison Catelano; Michael R Hendrickson; Hanina Hibshoosh; Lester J Layfield; Lorenzo Memeo; Hong Wu; Frances P O'Malley
Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(2):195-207.
2005: Teresa L Mastracci; Suzanna Tjan; Anita L Bane; Frances P O'Malley; Irene L Andrulis
E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(6):741-51.
2005: Anita L Bane; Suzanna Tjan; Robert K Parkes; Irene L Andrulis; Frances P O'Malley
Invasive lobular carcinoma: to grade or not to grade.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(5):621-8.
2004: Rosemary E Mueller; Robert K Parkes; Irene L Andrulis; Frances P O'Malley
Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.
Genes, chromosomes & cancer 2004;39(4):288-97.
2004: Jeremy R Parfitt; Chris Armstrong; Frances P O'Malley; Joan Ross; Alan B Tuck
In-situ and invasive carcinoma within a phyllodes tumor associated with lymph node metastases.
World journal of surgical oncology 2004;2():46.
2004: Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman F Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Breast cancer research : BCR 2004;6(4):R375-89.
2004: Frances P O'Malley; Anita L Bane
The spectrum of apocrine lesions of the breast.
Advances in anatomic pathology 2004;11(1):1-9.
2003: Yvan C Bédard; Aaron Pollett; Stephen W Leung; Frances P O'Malley
Assessment of thin-layer breast aspirates for immunocytochemical evaluation of HER2 status.
Acta cytologica 2003;47(6):979-84.
2002: E K Latta; Suzanna Tjan; Robert K Parkes; Frances P O'Malley
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(12):1318-25.
2002: Louise A Quenneville; Kelly-Anne Phillips; Hilmi Ozcelik; Robert K Parkes; Julia A Knight; Pamela J Goodwin; Irene L Andrulis; Frances P O'Malley
HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.
Cancer 2002;95(10):2068-75.
2002: Rosemary E Mueller; Frances P O'Malley
FISH detection of HER2 amplification in breast cancer.
Methods in molecular biology (Clifton, N.J.) 2002;204():353-67.
2001: Frances P O'Malley; Robert K Parkes; E Latta; Suzanna Tjan; T Zadro; R Mueller; N Arneson; Martin E Blackstein; Irene L Andrulis
Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry.
American journal of clinical pathology 2001;115(4):504-11.
1999: Alan B Tuck; D M Arsenault; Frances P O'Malley; Charulata Hota; M C Ling; Sylvia M Wilson; Ann F Chambers
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Oncogene 1999;18(29):4237-46.
1998: Alan B Tuck; Frances P O'Malley; H Singhal; JF Harris; Katia S Tonkin; Nancy Kerkvliet; Z Saad; Gordon S Doig; Ann F Chambers
Osteopontin expression in a group of lymph node negative breast cancer patients.
International journal of cancer. Journal international du cancer 1998;79(5):502-8.
1998: Z Saad; Vivien H C Bramwell; Sylvia M Wilson; Frances P O'Malley; J Jeacock; Ann F Chambers
Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases.
Lancet 1998;351(9110):1170-3.
1998: DN Mancini; David I Rodenhiser; Peter Ainsworth; Frances P O'Malley; Shiva M Singh; W Xing; Trevor K Archer
CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
Oncogene 1998;16(9):1161-9.
1997: EJ Tweedie; Katia S Tonkin; Nancy Kerkvliet; Gordon S Doig; R K Sparrow; Frances P O'Malley
Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study.
Clinical and investigative medicine. Médecine clinique et experimentale 1997;20(5):300-7.
1997: H Singhal; Frances P O'Malley; EJ Tweedie; L Stitt; Katia S Tonkin
Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Canadian journal of surgery. Journal canadien de chirurgie 1997;40(5):377-82.
1997: AG Casson; S M Wilson; J A McCart; Frances P O'Malley; Hilmi Ozcelik; Ming Tsao; A F Chambers
ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.
International journal of cancer. Journal international du cancer 1997;72(5):739-45.
1997: L Mack; Nancy Kerkvliet; Gordon S Doig; Frances P O'Malley
Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
Human pathology 1997;28(8):974-9.
1997: Alan B Tuck; Frances P O'Malley; H Singhal; Katia S Tonkin; JF Harris; D Bautista; Ann F Chambers
Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.
Archives of pathology & laboratory medicine 1997;121(6):578-84.
1997: H Singhal; D S Bautista; Katia S Tonkin; Frances P O'Malley; Alan B Tuck; Ann F Chambers; JF Harris
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(4):605-11.
1996: Ann F Chambers; Sylvia M Wilson; Nancy Kerkvliet; Frances P O'Malley; JF Harris; AG Casson
Osteopontin expression in lung cancer.
Lung cancer (Amsterdam, Netherlands) 1996;15(3):311-23.
1996: C J Engel; S T Bennett; Ann F Chambers; Gordon S Doig; Nancy Kerkvliet; Frances P O'Malley
Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging.
The American journal of surgical pathology 1996;20(10):1260-5.
1996: Frances P O'Malley; Z Saad; Nancy Kerkvliet; Gordon S Doig; L Stitt; Peter Ainsworth; H Hundal; Ann F Chambers; D I Turnbull; Vivien H C Bramwell
The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer.
Human pathology 1996;27(9):955-63.
1996: D S Bautista; Z Saad; Ann F Chambers; Katia S Tonkin; Frances P O'Malley; H Singhal; S Tokmakejian; Vivien H C Bramwell; JF Harris
Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women.
Clinical biochemistry 1996;29(3):231-9.
1995: AG Casson; Nancy Kerkvliet; Frances P O'Malley
Prognostic value of p53 protein in esophageal adenocarcinoma.
Journal of surgical oncology 1995;60(1):5-11.
1994: AG Casson; Nancy Kerkvliet; Frances P O'Malley; Richard Inculet; M Troster
p53 immunoreactivity in carcinosarcoma of the esophagus.
Journal of surgical oncology 1994;56(2):132-5.
1994: AG Casson; S McCuaig; I Craig; A Ayed; Richard Inculet; Nancy Kerkvliet; Frances P O'Malley
Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: a prospective study.
Journal of surgical oncology 1994;56(1):13-20.
1994: AG Casson; B Manolopoulos; M Troster; Nancy Kerkvliet; Frances P O'Malley; Richard Inculet; R Finley; J A Roth
Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.
American journal of surgery 1994;167(1):52-7.
1993: Frances P O'Malley; David Grignon; Michael Keeney; Nancy Kerkvliet; C McLean
DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate.
Cancer 1993;71(9):2797-802.
1993: David Grignon; Frances P O'Malley
Mucinous metaplasia in the prostate gland.
The American journal of surgical pathology 1993;17(3):287-90.
1991: Frances P O'Malley; David Grignon; R R Shepherd; L A Harker
Primary osteosarcoma of the kidney. Report of a case studied by immunohistochemistry, electron microscopy, and DNA flow cytometry.
Archives of pathology & laboratory medicine 1991;115(12):1262-5.
1990: Frances P O'Malley; David Grignon; D T Shum
Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.
Virchows Archiv. A, Pathological anatomy and histopathology 1990;417(3):191-6.